tolvaptan has been researched along with Hyperoxaluria, Primary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joher, N; Letavernier, E; Matignon, M; Mesnard, L; Moktefi, A; Stehlé, T | 1 |
1 other study(ies) available for tolvaptan and Hyperoxaluria, Primary
| Article | Year |
|---|---|
Tolvaptan to prevent calcium oxalate crystal deposition in the kidney allograft after kidney transplantation for primary hyperoxaluria.
Topics: Allografts; Calcinosis; Calcium Oxalate; Humans; Hyperoxaluria, Primary; Kidney; Kidney Transplantation; Tolvaptan | 2023 |